Naloxone Hydrochloride Injection, Solution
Product Images NDC 54288-124

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 54288-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bpi Labs Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton10 (Carton10)

Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) solution for intravenous, intramuscular, or subcutaneous use. The label indicates a package of 10 single-dose prefilled syringes. The product is labeled by BPI Labs LLC and states needle not included. The NDC on the label is 54288-124-10.*

FDA Label Image

Monocarton (Monocarton)

Packaging label for Naloxone Hydrochloride Injection, USP, 2 mg per 2 mL (1 mg/mL) from BPI Labs LLC. The label indicates the product is for intravenous, intramuscular, or subcutaneous use as an opioid antagonist. It includes a note that the needle is not included and that this is a single-dose prefilled syringe. The National Drug Code (NDC) is 54288-124-01.*

FDA Label Image

Structure (Structure)

Chemical structure of Naloxone Hydrochloride showing its molecular framework along with the chemical name (-)-17-Allyl-4,5α-epoxy-3,14-dihydroxy morphinan-6-one hydrochloride displayed next to the structure.*

FDA Label Image

Syringesketch (Syingedraw)

An illustration diagram showing labeled parts of a syringe device, including the tip cap, glass barrel, backstop, plunger stopper, and plunger rod. The syringe appears to be a detailed line drawing highlighting its structural components.*

FDA Label Image

Syringelabel (Syringe Label)

Label for Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) in a 2 mL single-dose prefilled syringe. The label includes the NDC 54288-124-01 and indicates use for intravenous, intramuscular, or subcutaneous administration. The product is manufactured by BPI Labs LLC, Largo, FL, USA and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.